Galapagos raises 300 million dollars

Thursday, 13 September 2018 15:34
The biotechnology company Galapagos has raised 300 USD in fresh money from American investors, via the issuing of new shares, it said Thursday.
The Mechelen company issued 2,575,107 new shares, at the price of 116.50 dollars per share.

The Bel 20 company announced Wednesday that its Filgotinib, a drug for rheumatism, has performed well in the phase III study, which facilitates a future commercialization.

The Brussels Times

 
Google Plus

More Stories

Circular sent to schools to cover young climate marchers

Circular sent to schools to cover young climate marchers

A circular meant to protect young people who skip school to march for the climate has been sent to all French-speaking schools in Belgium, Sudpresse newspapers reported on Tuesday.

Pilot project sees Brussels Airport hire 6 employees with autism

Pilot project sees Brussels Airport hire 6 employees with autism

A pilot project which has employed six people with autism spectrum disorder (ASD) to work at Brussels Airport is reporting positive results.

Ketamine, the new cocaine

Ketamine, the new cocaine

About one in five young people between the ages of 18 and 34 years who regularly attend electronic music events took ketamine last year.